Predicting Organ-Specific Risk Interactions between Radiation and Chemotherapy in Secondary Cancer Survivors by Venkata S.K. Manem, Clemens Grassberger, Harald Paganetti

Get full text

Radiation Therapy for Stage IIA/B Seminoma: Modeling Secondary Cancer Risk for Protons and VMAT versus 3D Photons by Jennifer Pursley, Kyla Remillard, Nicolas Depauw, Grace Lee, Clemens Grassberger, Harald Paganetti, Jason A. Efstathiou, Sophia C. Kamran

Get full text

A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals by Camilo M. Correa-Alfonso, Julia D. Withrow, Sean J. Domal, Shu Xing, Jungwook Shin, Clemens Grassberger, Harald Paganetti, Wesley E. Bolch

Get full text

Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions by Yejin Kim, Ibrahim Chamseddine, Yeona Cho, Jin Sung Kim, Radhe Mohan, Nadya Shusharina, Harald Paganetti, Steven Lin, Hong In Yoon, Seungryong Cho, Clemens Grassberger

Get full text

Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy by Susannah G. Ellsworth, MD, Anirudh Yalamanchali, MD, Tim Lautenschlaeger, MD, PhD, Stuart A. Grossman, MD, Clemens Grassberger, PhD, Steven H. Lin, MD, PhD, Radhe Mohan, PhD

Get full text

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients by Saba Ebrahimi, BSc, Gino Lim, PhD, Amy Liu, MSc, Steven H. Lin, MD, PhD, Susannah G. Ellsworth, MD, Clemens Grassberger, PhD, Radhe Mohan, PhD, Wenhua Cao, PhD

Get full text

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors by Jack M. Qian, MD, Elliot Akama-Garren, MS, Jungwook Shin, PhD, Lauren Gunasti, BA, Andrew Bang, MD, Luke R.G. Pike, MD, DPhil, Clemens Grassberger, PhD, Jonathan D. Schoenfeld, MD, MPH

Get full text

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC by Wang Jing, MD, Ting Xu, PhD, Lirong Wu, MD, Pablo B. Lopez, MD, Clemens Grassberger, PhD, Susannah G. Ellsworth, MD, Radhe Mohan, PhD, Brian P. Hobbs, PhD, George R. Blumenschein, MD, Janet Tu, MD, Mehmet Altan, MD, Percy Lee, MD, Zhongxing Liao, MD, Steven H. Lin, MD, PhD

Get full text